ICU antibiotic dosing study: do higher doses hit the mark?

NCT ID NCT02898961

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether giving higher doses of two common antibiotics (amikacin and gentamicin) to ICU patients with severe sepsis helps achieve the right levels in the blood. Researchers enrolled 63 critically ill adults to measure if the higher doses reached target concentrations. The goal was to improve dosing guidance for these life-threatening infections.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Nîmes

    Nîmes, Gard, 30029, France